Status:
TERMINATED
A Comparative Effectiveness Demonstration Project for Linkage and Retention in PrEP Care for Men Who Have Sex With Men
Lead Sponsor:
Johns Hopkins University
Collaborating Sponsors:
Gilead Sciences
Conditions:
Adherence, Patient
Eligibility:
MALE
18-99 years
Phase:
NA
Brief Summary
This research is being done to learn more about the differences in engaging, recruiting, linking and adhering to pre-exposure prophylaxis (PrEP) services for men who have sex with other men at risk fo...
Detailed Description
According to the Centers for Disease Control and Prevention (CDC), the estimated lifetime risk for HIV is 1 in 2 for Black men who have sex with men (MSM) and 1 in 4 for Latino MSM. In 2012, the U.S. ...
Eligibility Criteria
Inclusion
- 18 years of age or older who are HIV-negative and meeting CDC risk criteria
- Persons self-identifying as Black/African American, Latino or other men of color up to 20% Caucasian
- Men who report unprotected sex with another male partner in preceding twelve months
- Expressed interest in seeking HIV PrEP clinical services
- Willing to participate in study-related procedures, including baseline and study visits every three months
- Willing and able (i.e., access to internet connectivity) to participate in virtual PrEP model through EPIC, polycom platform
- Insured with plan that is accepted by Johns Hopkins (study team will conduct monthly tracking of insurance plans accepted by the Bartlett Specialty Care Clinic)
- Willing to receive PrEP care at Johns Hopkins
Exclusion
- Under 18 years of age
- Unable to read, write or speak English
- For medical reasons, are unable to receive TDF/FTC for PrEP (including HIV- positive persons)
- Participating in another PrEP clinical trial or HIV vaccination study
- Not insured with a plan that is accepted at Johns Hopkins
- Not willing or able (i.e. access to internet connectivity) to participate in virtual PrEP model
- Not willing to receive PrEP care at Johns Hopkins
Key Trial Info
Start Date :
July 30 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2021
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT03442192
Start Date
July 30 2018
End Date
December 31 2021
Last Update
December 9 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Johns Hopkins Hospital
Baltimore, Maryland, United States, 21287